416 related articles for article (PubMed ID: 28415726)
1. PGE2/EP3/SRC signaling induces EGFR nuclear translocation and growth through EGFR ligands release in lung adenocarcinoma cells.
Bazzani L; Donnini S; Finetti F; Christofori G; Ziche M
Oncotarget; 2017 May; 8(19):31270-31287. PubMed ID: 28415726
[TBL] [Abstract][Full Text] [Related]
2. Lyn, a Src family kinase, regulates activation of epidermal growth factor receptors in lung adenocarcinoma cells.
Sutton P; Borgia JA; Bonomi P; Plate JM
Mol Cancer; 2013 Jul; 12():76. PubMed ID: 23866081
[TBL] [Abstract][Full Text] [Related]
3. PLAUR Confers Resistance to Gefitinib Through EGFR/P-AKT/Survivin Signaling Pathway.
Zhou J; Kwak KJ; Wu Z; Yang D; Li J; Chang M; Song Y; Zeng H; Lee LJ; Hu J; Bai C
Cell Physiol Biochem; 2018; 47(5):1909-1924. PubMed ID: 29961070
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E2 reinforces the activation of Ras signal pathway in lung adenocarcinoma cells via EP3.
Yano T; Zissel G; Muller-Qernheim J; Jae Shin S; Satoh H; Ichikawa T
FEBS Lett; 2002 May; 518(1-3):154-8. PubMed ID: 11997037
[TBL] [Abstract][Full Text] [Related]
5. PML represses lung cancer metastasis by suppressing the nuclear EGFR-mediated transcriptional activation of MMP2.
Kuo HY; Huang YS; Tseng CH; Chen YC; Chang YW; Shih HM; Wu CW
Cell Cycle; 2014; 13(19):3132-42. PubMed ID: 25486572
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E2 activates Src signaling in lung adenocarcinoma cell via EP3.
Yamaki T; Endoh K; Miyahara M; Nagamine I; Thi Thu Huong N; Sakurai H; Pokorny J; Yano T
Cancer Lett; 2004 Oct; 214(1):115-20. PubMed ID: 15331179
[TBL] [Abstract][Full Text] [Related]
7. Signaling through the Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Axis Is Responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth Factor Receptor (EGFR)-mutated Lung Adenocarcinoma.
Makinoshima H; Takita M; Saruwatari K; Umemura S; Obata Y; Ishii G; Matsumoto S; Sugiyama E; Ochiai A; Abe R; Goto K; Esumi H; Tsuchihara K
J Biol Chem; 2015 Jul; 290(28):17495-504. PubMed ID: 26023239
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner.
Krysan K; Reckamp KL; Dalwadi H; Sharma S; Rozengurt E; Dohadwala M; Dubinett SM
Cancer Res; 2005 Jul; 65(14):6275-81. PubMed ID: 16024629
[TBL] [Abstract][Full Text] [Related]
9. RETRACTED: The receptor tyrosine kinase AXL mediates nuclear translocation of the epidermal growth factor receptor.
Brand TM; Iida M; Corrigan KL; Braverman CM; Coan JP; Flanigan BG; Stein AP; Salgia R; Rolff J; Kimple RJ; Wheeler DL
Sci Signal; 2017 Jan; 10(460):. PubMed ID: 28049763
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms involved in PGE2-induced transactivation of the epidermal growth factor receptor in MH1C1 hepatocarcinoma cells.
Tveteraas IH; Müller KM; Aasrum M; Ødegård J; Dajani O; Guren T; Sandnes D; Christoffersen T
J Exp Clin Cancer Res; 2012 Sep; 31(1):72. PubMed ID: 22967907
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of localization of epidermal growth factor receptor in lung adenocarcinoma.
Wang JL; Fang CL; Tzeng YT; Hsu HL; Lin SE; Yu MC; Bai KJ; Wang LS; Liu HE
J Biomed Sci; 2018 Jun; 25(1):53. PubMed ID: 29950164
[TBL] [Abstract][Full Text] [Related]
12. Gastrin-releasing peptide activates Akt through the epidermal growth factor receptor pathway and abrogates the effect of gefitinib.
Liu X; Carlisle DL; Swick MC; Gaither-Davis A; Grandis JR; Siegfried JM
Exp Cell Res; 2007 Apr; 313(7):1361-72. PubMed ID: 17349623
[TBL] [Abstract][Full Text] [Related]
13. Adenosine triphosphate regulates NADPH oxidase activity leading to hydrogen peroxide production and COX-2/PGE2 expression in A549 cells.
Lin CC; Lee IT; Wu WL; Lin WN; Yang CM
Am J Physiol Lung Cell Mol Physiol; 2012 Sep; 303(5):L401-12. PubMed ID: 22773695
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor reactivation induced by E-prostanoid-3 receptor- and tumor necrosis factor-alpha-converting enzyme-dependent feedback exaggerates interleukin-8 production in airway cancer (NCI-H292) cells.
Kim S; Lewis C; Nadel JA
Exp Cell Res; 2011 Nov; 317(18):2650-60. PubMed ID: 21925169
[TBL] [Abstract][Full Text] [Related]
15. Reciprocal Negative Regulation between EGFR and DEPTOR Plays an Important Role in the Progression of Lung Adenocarcinoma.
Zhou X; Guo J; Ji Y; Pan G; Liu T; Zhu H; Zhao J
Mol Cancer Res; 2016 May; 14(5):448-57. PubMed ID: 26896556
[TBL] [Abstract][Full Text] [Related]
16. Multiple signaling pathways are responsible for prostaglandin E2-induced murine keratinocyte proliferation.
Ansari KM; Rundhaug JE; Fischer SM
Mol Cancer Res; 2008 Jun; 6(6):1003-16. PubMed ID: 18567804
[TBL] [Abstract][Full Text] [Related]
17. EGF-like growth factors induce COX-2-derived PGE2 production through ERK1/2 in human granulosa cells.
Fang L; Cheng JC; Chang HM; Sun YP; Leung PC
J Clin Endocrinol Metab; 2013 Dec; 98(12):4932-41. PubMed ID: 24092824
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 induces stromal cell-derived factor-1 expression in prostate stromal cells by activating protein kinase A and transcription factor Sp1.
Peng Y; Shi J; Du X; Wang L; Klocker H; Mo L; Mo Z; Zhang J
Int J Biochem Cell Biol; 2013 Mar; 45(3):521-30. PubMed ID: 23246486
[TBL] [Abstract][Full Text] [Related]
19. Amplification of CRKL induces transformation and epidermal growth factor receptor inhibitor resistance in human non-small cell lung cancers.
Cheung HW; Du J; Boehm JS; He F; Weir BA; Wang X; Butaney M; Sequist LV; Luo B; Engelman JA; Root DE; Meyerson M; Golub TR; Jänne PA; Hahn WC
Cancer Discov; 2011 Dec; 1(7):608-25. PubMed ID: 22586683
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E2 promotes human cholangiocarcinoma cell proliferation, migration and invasion through the upregulation of β-catenin expression via EP3-4 receptor.
Du M; Shi F; Zhang H; Xia S; Zhang M; Ma J; Bai X; Zhang L; Wang Y; Cheng S; Yang Q; Leng J
Oncol Rep; 2015 Aug; 34(2):715-26. PubMed ID: 26058972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
